Mizuho Reiterates “Neutral” Rating for Marsh (NYSE:MRSH)

Marsh (NYSE:MRSH)‘s stock had its “neutral” rating reissued by Mizuho in a report issued on Friday, Marketbeat Ratings reports. They presently have a $199.00 price objective on the stock, down from their prior price objective of $213.00. Mizuho’s target price would suggest a potential upside of 6.67% from the stock’s current price.

MRSH has been the topic of a number of other research reports. Keefe, Bruyette & Woods boosted their target price on shares of Marsh from $205.00 to $206.00 and gave the company a “market perform” rating in a report on Monday, February 2nd. Raymond James Financial raised shares of Marsh from an “outperform” rating to a “strong-buy” rating and set a $225.00 price objective on the stock in a research note on Tuesday, February 17th. Morgan Stanley upped their price objective on shares of Marsh from $190.00 to $195.00 and gave the stock an “equal weight” rating in a report on Friday, January 30th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $200.00 target price on shares of Marsh in a report on Friday, January 30th. Finally, Citigroup boosted their price target on Marsh from $201.00 to $205.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 3rd. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $205.63.

Marsh Trading Up 0.7%

MRSH stock opened at $186.55 on Friday. Marsh has a fifty-two week low of $170.37 and a fifty-two week high of $248.00. The company has a market cap of $90.31 billion, a price-to-earnings ratio of 22.13, a PEG ratio of 2.62 and a beta of 0.75. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20.

Marsh (NYSE:MRSH) last released its quarterly earnings results on Thursday, January 29th. The company reported $2.12 earnings per share for the quarter, beating the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh had a return on equity of 31.60% and a net margin of 15.42%.The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.87 earnings per share.

Hedge Funds Weigh In On Marsh

Hedge funds have recently added to or reduced their stakes in the company. Solstein Capital LLC purchased a new stake in Marsh during the 4th quarter valued at $25,000. KERR FINANCIAL PLANNING Corp bought a new position in shares of Marsh during the fourth quarter valued at $27,000. Golden State Wealth Management LLC purchased a new stake in shares of Marsh during the fourth quarter valued at $27,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Marsh during the fourth quarter valued at $28,000. Finally, Ameriflex Group Inc. bought a new stake in Marsh in the 4th quarter worth about $32,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

More Marsh News

Here are the key news stories impacting Marsh this week:

• Positive Sentiment: Morgan Sindall’s chair accepted a non‑executive board role at Marsh & McLennan, adding outside board experience that investors generally view as governance strengthening and a positive for long‑term oversight. Morgan Sindall Chair Takes New Non-Executive Role at Marsh & McLennan
• Neutral Sentiment: Independent/industry analyses comparing Marsh to peers (e.g., a critical piece on Marsh and Cheche Group) provide additional context but contain mixed conclusions rather than clear buy/sell catalysts; these are informational rather than immediate triggers. Critical Analysis: Marsh (NYSE:MRSH) and Cheche Group (NASDAQ:CCG)
• Neutral Sentiment: Several recent sports headlines reference a baseball player named Brandon Marsh — these are unrelated to Marsh & McLennan and should be disregarded when assessing MRSH. (Example sports coverage linked for clarity.) Phillies’ Brandon Marsh: Held out with hand injury
• Negative Sentiment: Mizuho reaffirmed a “neutral” rating but lowered its price target from $213 to $199, trimming expected upside and signaling slightly more conservative near‑term expectations; a lower PT can dampen momentum even though the firm left the rating unchanged. Benzinga Finviz

About Marsh

Marsh is a global insurance broker and risk advisor that helps organizations assess, manage and transfer a broad range of risks. The firm provides insurance placement and broking services for commercial and public-sector clients as well as specialty solutions for families and high-net-worth individuals. Its work focuses on identifying exposures, designing risk-transfer strategies and securing coverage from insurers and reinsurers to protect clients’ assets and operations.

Services offered by Marsh include commercial property and casualty broking, cyber and professional-liability placement, employee benefits consulting, and industry-specific specialty lines such as marine, energy and construction.